The drug, made by Eli Lilly, could offer a more convenient option for patients who want to avoid injections.
Source link : https://www.nytimes.com/2026/04/01/well/fda-obesity-pill-orfoglipron.html
Author : Dani Blum and Rebecca Robbins
Publish date : 2026-04-01 20:44:00
Copyright for syndicated content belongs to the linked Source.